| Literature DB >> 26404289 |
Xiaofeng Zhang1,2, Andrew Fales3, Tuan Vo-Dinh4,5,6.
Abstract
This article presents our most recent advances in synchronous fluorescence (SF) methodology for biomedical diagnostics. The SF method is characterized by simultaneously scanning both the excitation and emission wavelengths while keeping a constant wavelength interval between them. Compared to conventional fluorescence spectroscopy, the SF method simplifies the emission spectrum while enabling greater selectivity, and has been successfully used to detect subtle differences in the fluorescence emission signatures of biochemical species in cells and tissues. The SF method can be used in imaging to analyze dysplastic cells in vitro and tissue in vivo. Based on the SF method, here we demonstrate the feasibility of a time-resolved synchronous fluorescence (TRSF) method, which incorporates the intrinsic fluorescent decay characteristics of the fluorophores. Our prototype TRSF system has clearly shown its advantage in spectro-temporal separation of the fluorophores that were otherwise difficult to spectrally separate in SF spectroscopy. We envision that our previously-tested SF imaging and the newly-developed TRSF methods will combine their proven diagnostic potentials in cancer diagnosis to further improve the efficacy of SF-based biomedical diagnostics.Entities:
Keywords: cancer diagnosis; imaging; synchronous fluorescence; time-resolved; ultrafast
Mesh:
Substances:
Year: 2015 PMID: 26404289 PMCID: PMC4610566 DOI: 10.3390/s150921746
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Conventional fixed-excitation fluorescence of a five-component mixture (upper curve, 258 nm excitation) and the SF spectrum of the same mixture showing improved spectral component separation (lower curve, 3 nm wavelength interval). Adapted from [8].
Figure 2Schematic of the synchronous fluorescence imaging system. Adapted from [45].
Figure 3Schematic of the time-resolved synchronous fluorescence (TRSF) system.
Figure 4Fluorescence and standard SF spectra of methylene blue, oxazine 170, and their mixture. (a) conventional fluorescence emission spectra of methylene blue (blue solid line) and oxazine 170 (red broken line); (b) standard SF spectra of methylene blue (blue solid line) and oxazine 170 (red broken line); (c) conventional fluorescence spectra of the mixture of methylene blue and oxazine 170, excited at 614 nm (blue solid line) and 655 nm (red broken line); and (d) standard SF spectrum of the mixture of methylene blue and oxazine 170 (wavelength interval of 20 nm).
Figure 5SF and TRSF spectra acquired using the TRSF system: linear contour plots of the TRSF spectra of (a) methylene blue (MB); (b) oxazine 170 (O170); (c) their mixture (MB + O170); and (d–f) SF spectra derived from the same data sets, respectively.
Figure 6Time-delayed SF (“Delayed SF”) plots derived from the TRSF data set of (a) methylene blue (MB); (b) oxazine 170 (O170); and (c) the mixture of the two fluorophores (MB + O170).